Skip to content
ChickenStockChickenStock
ResearchCLGN
Collplant Biotechnologies logo

Collplant Biotechnologies (CLGN) stock

NASDAQ

$4.640.00%(0.00)

As of the Nov 17, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · not confirmed · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

-1.27x

Net loss — not comparable

P/B

2.33x

P/S

7.00x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

May–Jul 2024(FY2024 Q2)

No later quarterly filing was found for this company, so this shows the most recent quarter on record.

Operating income decreased 166.7% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Aug 20, 2024 · 6-K · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

2 SEC filings
  • Abelis Bar BertaVP Legal · Sep 3, 2026Grant or award201,141 shares · $0
    Avg. price $0206,441 shares held after
  • Rotem EranDeputy CEO and CFO · Sep 3, 2026Grant or award510,372 shares · $0
    Avg. price $0516,372 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Collplant Biotechnologies (CLGN) stock information

NASDAQ

Collplant Biotechnologies (CLGN) is listed on NASDAQ. Its market capitalization is about $14M. On trailing-twelve-month earnings the P/E ratio is -1.27, and the P/B ratio is 2.33. Return on equity is -183.3%. These figures are computed in-house from official filings and are reference information only.

Collplant Biotechnologies — frequently asked questions

What is the P/E ratio of Collplant Biotechnologies (CLGN)?
On a trailing-twelve-month basis, CLGN trades at a P/E ratio of -1.27. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Collplant Biotechnologies?
CLGN has a market capitalization of about $14M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.